Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ondansetron (2mg)
Therapeutic Category
Gastroenterology
Dosage Form
Injection
Packaging Type
vial
Packaging
10*2 ml
Price
₹13.35/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ondotyle Injection, containing Ondansetron (2mg), is a fast-acting antiemetic designed to prevent and treat nausea and vomiting in various medical situations. Ondansetron, a selective serotonin (5-HT3) receptor antagonist, works by blocking the action of serotonin in the brain and gastrointestinal tract, which are key triggers for nausea and vomiting. This makes it highly effective for use during chemotherapy, radiotherapy, and after surgical procedures, where these symptoms are common.
Ondotyle Injection is administered intravenously or intramuscularly, ensuring rapid action and providing relief when oral administration is not feasible. Its targeted mechanism of action and reliable efficacy make it a preferred choice for healthcare professionals in managing acute and severe cases of nausea and vomiting.
Common side effects may include headache, dizziness, constipation, or mild abdominal discomfort. Rare but serious effects such as allergic reactions, irregular heartbeat, or changes in blood pressure may occur.
Ondotyle Injection is indicated for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, postoperative recovery, and gastrointestinal disturbances.
This injection should only be administered under the supervision of a qualified healthcare professional. Do not exceed the recommended dose. Discontinue use and consult a doctor immediately if adverse effects occur.
Store below 25°C in a cool, dry place, protected from light. Keep out of reach of children.
Composition : Calcium Carbonate (1250mg) + Vitamin D3 (250 IU) Tablet
Composition : Cissus quadrangularis (500mg), Calcium citrate malate (500mg), Calcitriol, Vitamin K2-7 (0.25mcg), Methylcobalamin, Folic acid and Zinc (300mcg) Tablet
Composition : Methylcobalamin I.P. 500mcg + Vitamin A I.P. 5000 IU + Vitamin D3 I.P. 400 IU + Vitamin E I.P. 25mg + Calcium Pantothenate I.P. 50mg + L-Glutamin Acid USP 50mg + Vitamin B1 I.P. 10mg + Riboflavin I.P. 10mg + Vitamin B6 I.P. 3mg + Niacinamide I.P. 50mg + Vitamin C I.P.75mg + Biotin USP 260mcg + Folic Acid I.P. 1mg + Zinc Sulphate Monohydrate I.P. 60mg + Chromium Picolinate USP 150mcg + Selenium Dioxide USP 100mcg + Manganese Sulphate B.P. 200mcg + Magnesium Hydroxide I.P. 10mg + Copper Sulphate Pentahydrate B.P. 200mcg
Composition : Grape Seed Extract 50mg + Vitamin C 40mg + Vitamin B3 18mg + Vitamin E 10mg + Zinc 10mg + Vitamin B2 1.6mg + VitaminB1 1.4mg + Vitamin B6 1mg + Vitamin A 600 µg + Manganese 250µg + Folic Acid 100µg + Iodine 100µg + Biotin 30µg + Copper 30µg + Selenium 25µg + Vitamin D3 5µg + Vitamin B12 1 Tablets
Composition : Carica Papaya (1100mg) + Tinospora (400mg) + Goat Milk Powder (100mg)
Composition : Levo-carnitine (500mg) + Methylcobalamin (1500mcg) + Folic Acid (1.5mg)
Composition : Myo-Inositol (500mg) + Berberine Extract (277mg) + D-Chiro-Inositol (12.5mg) + L-Methyl Folate (45mcg) + Vitamin D2 (90 IU) Tablet
Composition : Ferrous Ascorbate (100mg) + Folic Acid (1.5mg) + Zinc (22.5mg)
Composition : Ferrous Bisglycinate (60mg) + Zinc bisglycinate (15mg) + Folic Acid (1mg) + Methylcobalamin (500mcg)
Composition : L-Ornithine L-Aspartate (250mg) + Silymarin (70mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Ondansetron 2 mg Injection is a fast-acting antiemetic formulation used for the management of nausea and vomiting caused by chemotherapy, radiotherapy, surgery (post-operative), gastroenteritis, and other acute medical conditions. It works by blocking serotonin (5-HT3) receptors, providing rapid control of vomiting and improving patient comfort. It is a valuable hospital care, emergency, and antiemetic injectable segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand from hospitals, emergency wards, surgical units, oncologists, and physicians. Anti-vomiting injectables are essential in both inpatient and emergency care protocols, ensuring steady institutional procurement, repeat orders, and continuous hospital usage.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the critical care, antiemetic, and hospital injectable segments with monopoly rights, quality manufacturing standards, strict regulatory compliance, and reliable supply support for distributors and medical agencies.
Wholesalers and institutional suppliers benefit from high hospital usage, protocol-based prescribing, surgical and chemotherapy-related demand, and continuous emergency case requirements, making it a stable and high-value pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in hospital care and antiemetic injectable formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the critical care segment.